Diabetes in pregnancy: are we providing the best care ... - HQIP
Diabetes in pregnancy: are we providing the best care ... - HQIP
Diabetes in pregnancy: are we providing the best care ... - HQIP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table 11.10<br />
Differences <strong>in</strong> postnatal c<strong>are</strong> bet<strong>we</strong>en women with type 1 and type 2 diabetes<br />
Women with type 1<br />
diabetes<br />
n/N (%)<br />
Women with type 2<br />
diabetes<br />
n/N (%)<br />
p-value<br />
No postnatal contraceptive advice 21/137 (15) 31/105 (30) 0.008<br />
No written plan for post-delivery<br />
diabetes management 20/156 (13) 15/115 (13) 0.95<br />
Assessment of suboptimal<br />
postnatal diabetes c<strong>are</strong> 93/177 (53) 59/127 (46) 0.3<br />
11.9 Conclusions<br />
The comparison of women with type 1 and type 2 diabetes has shown some differences <strong>in</strong> cl<strong>in</strong>ical<br />
characteristics (Body Mass Index, ret<strong>in</strong>opathy and frequency and severity of hypoglycaemia <strong>in</strong> <strong>pregnancy</strong>)<br />
which <strong>are</strong> to be expected from <strong>the</strong> difference <strong>in</strong> disease profi les bet<strong>we</strong>en <strong>the</strong> two groups of women.<br />
It is concern<strong>in</strong>g that women with type 2 diabetes <strong>we</strong>re less likely than women with type 1 diabetes to have<br />
a ret<strong>in</strong>al assessment <strong>in</strong> <strong>the</strong> fi rst trimester (or at book<strong>in</strong>g if later), especially s<strong>in</strong>ce ret<strong>in</strong>opathy was a new<br />
fi nd<strong>in</strong>g <strong>in</strong> fi ve out of <strong>the</strong> n<strong>in</strong>e women with type 2 diabetes who had ret<strong>in</strong>opathy <strong>in</strong> <strong>pregnancy</strong>. This may<br />
refl ect a perception by health professionals that type 2 diabetes is less likely to cause complications than<br />
type 1 diabetes, and highlights <strong>the</strong> importance of early and regular ret<strong>in</strong>al assessment for all women with<br />
pre-exist<strong>in</strong>g diabetes.<br />
Before <strong>pregnancy</strong>, women with type 2 diabetes <strong>we</strong>re less likely than women with type 1 diabetes to have a<br />
ret<strong>in</strong>al assessment or test for album<strong>in</strong>uria <strong>in</strong> <strong>the</strong> 12 months before <strong>pregnancy</strong>. Women with type 2 diabetes<br />
<strong>are</strong> more likely to be managed <strong>in</strong> primary c<strong>are</strong>, and this fi nd<strong>in</strong>g may <strong>the</strong>refore refl ect a lack of aw<strong>are</strong>ness<br />
by primary c<strong>are</strong> professionals of <strong>the</strong> importance of screen<strong>in</strong>g for diabetes complications <strong>in</strong> women with<br />
type 2 diabetes. There may also be diffi culties <strong>in</strong> access<strong>in</strong>g <strong>in</strong>vestigations such as ret<strong>in</strong>al photographs that<br />
<strong>are</strong> usually provided <strong>in</strong> <strong>the</strong> secondary c<strong>are</strong> sett<strong>in</strong>g.<br />
Women with type 2 diabetes <strong>we</strong>re less likely to receive postnatal contraceptive advice. It is recognised that<br />
health professionals may fi nd it diffi cult to provide contraceptive advice to women from different cultural<br />
backgrounds due to language diffi culties and perceived cultural sensitivities. Ho<strong>we</strong>ver, this is a vital aspect<br />
of post-delivery counsell<strong>in</strong>g, and every effort should be made by health professionals to help women with<br />
diabetes, <strong>in</strong>clud<strong>in</strong>g those with type 2 diabetes, to prep<strong>are</strong> adequately for future pregnancies.<br />
79